Norris Medicines quarterly results and financials

Norris Medicines (BSE 524414)₹14.25−5.00%(9 Nov 2026 close)Trading & Distributors

Key facts

In the Mar 2026 quarter (standalone), Norris Medicines reported sales of ₹1.40 Cr, down 48.3% from Mar 2025, and net profit of ₹0.06 Cr. For the year to Mar 2026, sales were ₹8.10 Cr and net profit −₹0.29 Cr.

Sales (Mar 2026): ₹1.40 Cr
Net profit (Mar 2026): ₹0.06 Cr
Sales (FY Mar 2026): ₹8.10 Cr
Net profit (FY Mar 2026): −₹0.29 Cr
EPS (Mar 2026): ₹0.06
Borrowings (Mar 2026): ₹21.60 Cr

Company filings, standalone accounts; latest reported quarter Mar 2026

Norris Medicines quarterly results

₹ crore unless stated; each column is a quarter.

Norris Medicines Quarterly results
	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	0.94	2.55	0.64	1.48	0.71	1.26	1.10	2.71	1.45	1.99	3.26	1.40
Expenses	1.32	2.79	0.68	1.00	0.87	1.41	1.13	2.64	1.55	2.48	2.31	1.10
Operating Profit	−0.37	−0.23	−0.05	0.47	−0.17	−0.16	−0.04	0.06	−0.11	−0.50	0.96	0.31
OPM %	−40.1%	−9.5%	−6.2%	32.2%	−22.3%	−11.9%	−2.7%	2.6%	−6.9%	−24.6%	29.0%	21.2%
Other Income	0.00	0.00	0.00	0.04	0.02	0.00	0.00	0.06	0.03	0.00	0.00	0.03
Interest	0.08	0.08	0.08	0.10	0.07	0.07	0.11	0.14	0.10	0.10	0.12	0.14
Depreciation	0.15	0.15	0.15	0.13	0.12	0.14	0.12	0.15	0.13	0.13	0.13	0.13
Profit before tax	−0.62	−0.48	−0.28	0.27	−0.37	−0.37	−0.29	−0.18	−0.32	−0.73	0.71	0.06
Tax %	0.0%	0.0%	0.0%	34.7%	0.0%	0.0%	0.0%	35.4%	0.0%	0.0%	0.0%	0.0%
Net Profit	−0.62	−0.47	−0.28	0.18	−0.36	−0.37	−0.29	−0.24	−0.30	−0.73	0.71	0.06
EPS (Rs)	−0.62	−0.49	−0.28	0.18	−0.38	−0.37	−0.29	−0.24	−0.32	−0.73	0.71	0.06

Norris Medicines profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Norris Medicines Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	18.82	20.41	13.54	16.22	7.81	12.22	9.42	8.33	5.62	5.80	8.10	8.10
Expenses	18.00	20.42	15.45	16.84	9.98	13.97	9.51	7.42	5.80	6.07	7.46	7.44
Operating Profit	0.84	0.00	−1.93	−0.62	−2.17	−1.76	−0.09	0.94	−0.16	−0.25	0.67	0.66
OPM %	4.4%	0.0%	−14.2%	−3.8%	−27.6%	−14.4%	−0.9%	11.1%	−3.0%	−4.5%	8.1%	8.2%
Other Income	0.31	0.07	0.15	0.05	0.10	0.06	0.04	0.02	0.02	0.07	0.06	0.06
Interest	0.66	0.59	0.69	0.72	0.87	1.62	1.47	1.49	0.36	0.43	0.49	0.46
Depreciation	0.61	0.66	0.70	0.72	0.72	0.68	0.67	0.62	0.56	0.55	0.50	0.52
Profit before tax	−0.15	−1.20	−3.20	−2.02	−3.69	−4.01	−2.20	−1.20	−1.11	−1.19	−0.29	−0.28
Tax %	−128.5%	−35.3%	−21.0%	−16.4%	−22.8%	24.3%	49.4%	47.2%	8.2%	5.1%	0.0%	—
Exceptional items	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—
Net Profit	0.03	−0.78	−2.52	−1.69	−2.83	−4.97	−3.27	−1.76	−1.20	−1.25	−0.29	−0.26
EPS (Rs)	0.05	−0.78	−2.52	−1.69	−2.85	−4.97	−3.27	−1.76	−1.20	−1.25	−0.29	−0.28
Dividend payout %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

Norris Medicines balance sheet

₹ crore, at each year end.

Norris Medicines Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	9.94	9.94	9.92	9.94	9.92	9.92	9.94	9.92	9.93	9.93	9.91	9.92
Reserves	−4.62	−4.59	−5.35	−7.87	−9.53	−12.38	−17.33	−20.62	−22.36	−23.54	−24.77	−25.05
Borrowings	8.19	7.53	7.59	7.73	11.28	17.97	15.56	21.13	21.43	21.56	21.63	21.60
Other Liabilities	4.66	5.05	9.90	10.90	8.73	5.08	11.63	3.78	4.70	6.26	7.06	6.46
Total Liabilities	18.17	17.93	22.06	20.70	20.40	20.59	19.80	14.21	13.70	14.21	13.83	12.93
Fixed Assets	8.58	8.32	9.94	9.29	8.87	8.22	7.64	7.05	6.45	5.78	5.25	4.78
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02
Other Assets	9.57	9.59	12.10	11.39	11.51	12.35	12.14	7.14	7.23	8.41	8.56	8.13
Inventories	2.51	3.43	3.70	4.48	3.77	4.02	5.12	2.43	3.21	4.34	4.14	3.99
Trade receivables	3.76	2.76	4.71	2.46	3.00	2.75	1.78	1.08	1.09	1.05	1.40	1.16
Cash & equivalents	0.19	−0.10	0.04	0.09	0.07	0.05	0.01	0.01	0.01	0.03	0.03	0.01
Total Assets	18.17	17.93	22.06	20.70	20.40	20.59	19.80	14.21	13.70	14.21	13.83	12.93

Norris Medicines cash flow

₹ crore, for each year.

Norris Medicines Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	−1.42	1.34	−0.95	0.79	−1.91	−2.87	1.10	−1.00	1.19	0.16	0.50	0.57
Cash from investing activity	−0.89	−0.35	−2.06	−0.09	−0.30	0.00	−0.07	−0.10	−0.03	0.06	0.00	−0.09
Cash from financing activity	0.11	−1.33	3.17	−0.67	2.19	2.87	−1.10	1.11	−1.19	−0.21	−0.51	−0.53
Net cash flow	−2.22	−0.32	0.16	0.07	−0.03	−0.03	−0.05	0.00	0.00	0.03	0.00	−0.03
Capex	0.86	0.31	2.27	0.05	0.28	0.07	0.08	0.05	0.02	0.00	0.01	0.00
Free cash flow	−2.31	1.04	−3.25	0.75	−2.22	−2.97	1.03	−1.08	1.18	0.27	0.50	0.58
CFO / OP %	−83.9%	163.1%	—	−41.9%	315.0%	133.1%	−62.9%	1,262.1%	129.1%	−99.9%	−195.9%	88.1%

Norris Medicines ratios

Working-capital days and returns, by year.

Norris Medicines Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	74	54	84	66	68	128	53	42	48	69	88	53
Inventory days	100	134	130	239	135	324	213	157	348	594	437	338
Days payable	113	100	126	253	141	234	220	88	151	245	273	223
Cash conversion cycle	62	89	88	53	63	219	47	113	246	419	253	168
Working capital days	27	34	−17	−92	−34	−32	−105	−99	−123	−204	−242	−169
ROCE %	4.0%	4.0%	−4.1%	−22.9%	−12.0%	−20.7%	−20.1%	−7.7%	3.2%	−8.4%	−10.1%	3.4%

Norris Medicines: frequently asked questions

What are the latest quarterly results of Norris Medicines?

For the Mar 2026 quarter, Norris Medicines reported sales of ₹1.40 Cr, down 48.3% year on year and net profit of ₹0.06 Cr. The operating margin was 21.2%.

What is the annual revenue of Norris Medicines?

Norris Medicines' sales for the year to Mar 2026 were ₹8.10 Cr; over the last twelve months they were ₹8.10 Cr.

What is the net profit of Norris Medicines?

Net profit for the year to Mar 2026 was −₹0.29 Cr, and −₹0.26 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−0.28.

How much debt does Norris Medicines have?

Norris Medicines reported borrowings of ₹21.60 Cr at Mar 2026, against cash and equivalents of ₹0.01 Cr.

What is the free cash flow of Norris Medicines?

Cash from operations was ₹0.57 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹0.58 Cr.

Loading…